Enter your login e-mail to the account
Search
- CHEMOTHERAPY OF HORMONALLY REFRACTORY PROSTATIC CARCINOMA
doc. MUDr. Jozef Mardiak, CSc.
(2/2007, Review articles )
- PHARMACOECONOMICS – ITS POSITION IN DRUG POLICY
prof. RNDr. Viliam Foltán, CSc., Mgr. Veronika Dubajová, PharmDr. Tomáš Tesař, PHD, MBA
(1/2008, Review articles ) - Chemotherapy of hormonally refractory prostatic carcinoma
doc. MUDr. Jozef Mardiak, CSc.
(1/2007, Review articles ) - A patient with metastatic colorectal adenocarcinoma treated with chemotherapy in combination with bevacizumab
MUDr. Michal Mego, PhD., MUDr. Zuzana Syčová-Milá, MUDr. Jana Obertová, MUDr. Patrik Palacka, PhD., MUDr. Ján Rajec, PhD., doc. MUDr. Jozef Mardiak, CSc., mim. prof.
(1/2011, Original articles & case reports ) - CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(2/2008, Review articles ) - Late effects after anticancer therapy in childhood
doc. MUDr. Beáta Mladosievičová, CSc.
(1/2009, Review articles ) - Selected drug interactions in oncology
MUDr. Veronika Ballová, MUDr. Ján Rajec, PhD.
(5/2011, Review articles ) - The cytoreductive surgery and HIPEC in the treatment of locally progressive malignities of abdominal cavity and carcinomatosis
MUDr. Karel Kroupa, PhD.
(5/2010, Original articles & case reports ) - Gravidita po onkologickej liečbe
MUDr. Katarína Rejleková, PhD.
(3/2018, Review articles ) - Genetic perspectives in prediction of cytostatic toxicity
prof. MUDr. László Kovács, DrSc., MPH, MUDr. Sabína Šufliarska, MUDr. Alica Dzurenková, doc. MUDr. Beáta Mladosievičová, CSc., RNDr. Gabriel Minárik, PhD.
(4/2009, Review articles ) - Antineoplastic treatment of patients with renal insufficency
MUDr. Ján Rajec, PhD., doc. MUDr. Michal Mego, PhD.
(2/2011, Review articles ) - Palliative radiotherapy – brain metastatic disease
MUDr. Elena Bolješíková, CSc., MUDr. Martin Chorváth
(5/2013, Main topic ) - Recommendations for the management of central venous access devices in oncologic and hematologic patients in the Slovak Republic
MUDr. Ivan Dekánek, MUDr. Barbora Kašperová, MUDr. Maroš Kunderlík, MUDr. Erika Rauschová, MUDr. Martin Rázus, MUDr. Martin Sedmina, MUDr. Ladislav Sopko, PhD., MHA, doc. MUDr. Ľuboš Drgoňa, CSc., MHA, FECMM, prof. MUDr. Michal Mego, DrSC., MUDr. Alexander Wild, PhD., doc. MUDr. Peter Rohoň, PhD.
(S3/2023, Supplement ) - News in systemic treatment of ovarian cancer
MUDr. Michaela Sojáková, PhD.
(6/2018, Review articles ) - Conservative treatment of rare thoracic tumors – thymoma and carcinoid
MUDr. Mária Černá, CSc.
(6/2011, Review articles ) - Esenciálna trombocytémia – mení sa niečo v diagnostike a liečbe v roku 2018?
Prof. MUDr. Mikuláš Hrubiško, CSc.
(4/2018, Spectrum ) - Glukokortikoidy v liečbe kastračne-rezistentného karcinómu prostaty a mechanizmy rezistencie na androgénnu blokádu
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2018, Review articles )
- Nanotechnology in medicine
Prof. MUDr. Danka Švecová, PhD.
(2/2017, Review articles )
- The nurse’s role in caring for a child during chemotherapy
Bc. Eva Cimbálníková, doc. Ing. Iva Brabcová, Ph.D.
(1-2e/2018, Nursing )